Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have all the necessary information to write a comprehensive answer. Let me compile everything.

Myocardial Infarction - Complete Review

Definition

Myocardial infarction (MI), commonly called a "heart attack," is necrosis of cardiac muscle resulting from prolonged ischemia. The 2018 joint task force of U.S. and European Cardiology groups defines it as "the presence of acute myocardial injury detected by abnormal cardiac biomarkers in the setting of evidence of acute myocardial ischemia."

Classification

By ECG Pattern (Clinically Most Used)

TypeECGPathology
STEMI (ST-elevation MI)ST segment elevationTransmural infarct; complete coronary occlusion
NSTEMI (Non-ST-elevation MI)No ST elevationSubendocardial / partial thickness; incomplete occlusion
Unstable AnginaMay be normalNo biomarker rise; ischemia without necrosis
STEMI is invariably due to complete coronary artery occlusion and requires urgent thrombolysis or stenting. NSTEMI can often be managed conservatively.

By Depth

  • Transmural MI - full thickness of myocardial wall involved; corresponds to STEMI
  • Subendocardial MI - limited to inner 1/3 to 1/2 of myocardial wall; corresponds to NSTEMI

Fourth Universal Definition (Type Classification)

TypeCause
Type 1Spontaneous MI from atherothrombosis (plaque rupture/erosion)
Type 2MI due to supply-demand mismatch (e.g., vasospasm, tachycardia, anemia)
Type 3MI causing death before biomarkers can be confirmed
Type 4a/bPercutaneous coronary intervention (PCI)-related MI
Type 5CABG surgery-related MI

By Territory (based on coronary artery affected)

  • LAD occlusion - anterior, anteroseptal, anterolateral wall of LV (most common; "widow maker")
  • RCA occlusion - posterior, inferior wall of LV; right ventricle
  • LCx occlusion - lateral wall of LV

Etiopathogenesis

Risk Factors

  • Non-modifiable: Age, male sex, family history; approximately 10% of MIs occur below age 40
  • Modifiable: Hypertension, hyperlipidemia, diabetes, smoking, obesity, sedentary lifestyle
  • Women are protected during reproductive years due to estrogen; risk rises post-menopause

Pathogenesis Sequence (Atherothrombotic, ~90% of cases)

  1. An atheromatous plaque is eroded or suddenly disrupted by endothelial injury, intraplaque hemorrhage, or mechanical forces - exposing subendothelial collagen and necrotic plaque contents to blood
  2. Platelets adhere, aggregate, and activate - releasing thromboxane A2, ADP, and serotonin, causing further aggregation and vasospasm
  3. Coagulation is activated by tissue factor exposure, adding to the growing thrombus
  4. Within minutes, the enlarging thrombus completely occludes the coronary lumen
Angiography within 4 hours of MI onset shows coronary thrombosis in ~90% of cases.

Non-atherothrombotic Causes (~10%)

  • Coronary artery vasospasm (cocaine, ephedrine use)
  • Embolism from mural thrombus (atrial fibrillation), valvular vegetations, paradoxical embolism
  • Vasculitis, amyloid deposition, sickle cell disease (small vessel occlusion)

Myocardial Response to Ischemia

TimeEvent
SecondsATP depletion begins; aerobic metabolism ceases
< 2 minLoss of contractility
10 minATP reduced to 50% of normal
20-40 minIrreversible cell injury begins (necrosis threshold)
40 minATP reduced to 10% of normal
> 1 hourMicrovascular injury
6-12 hoursProgressive necrosis becomes complete
The critical window is 20-40 minutes - severe ischemia lasting beyond this leads to irreversible myocyte death. The rationale for rapid reperfusion is to salvage as much at-risk myocardium as possible ("time is myocardium").
Necrosis begins in the subendocardial zone (most distal from epicardial vessels, exposed to high intramural pressures) and spreads as a "wavefront" toward the epicardium with prolonged ischemia.

Pathology: Morphology / Sequential Changes Over Time

(Robbins & Kumar Basic Pathology)
Time FrameGross AppearanceLight MicroscopyEM Findings
0-½ hrNoneNoneMyofibril relaxation; glycogen loss; mitochondrial swelling
½-4 hrNoneUsually none; wavy fibers at borderSarcolemmal disruption; mitochondrial amorphous densities
4-12 hrOccasionally dark mottlingOnset of coagulation necrosis; edema; hemorrhage-
12-24 hrDark mottlingOngoing coagulation necrosis; pyknotic nuclei; hypereosinophilic myocytes; marginal contraction band necrosis; early neutrophilic infiltrate-
1-3 daysMottling with yellow-tan infarct centerCoagulation necrosis with loss of nuclei and striations; increased neutrophils-
3-7 daysHyperemic border; central yellow-tan softeningNeutrophil disintegration; early macrophage phagocytosis at border-
7-10 daysMaximally yellow-tan and soft; depressed red-tan marginsWell-developed macrophage phagocytosis; early granulation tissue at margins-
10-14 daysRed-gray depressed infarct bordersWell-established granulation tissue with new vessels and collagen deposition-
2-8 weeksGray-white scar, progressing from border to coreIncreased collagen deposition; decreased cellularity-
> 2 monthsScarring completeDense collagenous scar-

Key Microscopic Features

  • Wavy fibers (½-4 hrs): stretching and buckling of non-contractile dead fibers at infarct edges
  • Coagulation necrosis: preservation of cell outlines but loss of nuclei (4-12 hrs onward)
  • Contraction band necrosis: particularly seen in reperfused infarcts - intense eosinophilic transverse bands formed by hypercontracted sarcomeres due to calcium influx
  • Neutrophil infiltration: peaks 1-3 days
  • Macrophage phagocytosis: peaks 5-10 days
  • Granulation tissue: appears 1-2 weeks
  • Dense collagenous scar: complete by 6 weeks

Reperfusion Injury

Restoring blood flow to ischemic tissue can cause additional damage. Mechanisms include:
  • Mitochondrial dysfunction (membrane permeability → swelling → apoptosis)
  • Myocyte hypercontracture (calcium overload)
  • Free radical generation (superoxide, H2O2, peroxynitrite)
  • Leukocyte aggregation causing microvascular "no-reflow" phenomenon

Laboratory Diagnosis (Cardiac Biomarkers)

The basis is measurement of intracellular proteins that leak from necrotic myocytes through damaged sarcolemmal membranes into the circulation.

Biomarker Kinetics

Cardiac Biomarkers After MI
(Robbins & Kumar Basic Pathology, Fig. 9.13 - Acute increases in Troponin I, CK-MB, and Myoglobin following MI)

Enzyme/Biomarker Changes Summary

MarkerRisePeakReturns to NormalNotes
Myoglobin1-4 hrs6-9 hrs24-36 hrsEarliest to rise; low cardiac specificity
CK-MB (creatine kinase-MB isoform)2-4 hrs24-48 hrs~72 hrsTraditionally used; now largely replaced by troponins
Troponin I (cTnI)2-4 hrs~48 hrs7-10 daysHigh cardiac specificity and sensitivity; preferred marker
Troponin T (cTnT)2-4 hrs~48 hrs7-14 daysHigh cardiac specificity; same kinetics as TnI
LDH (LDH-1 isoform)24-48 hrs3-5 days10-14 daysUseful for late diagnosis; LDH-1 > LDH-2 = "flipped LDH"
AST12-24 hrs36-48 hrs3-5 daysNon-specific; less used now
Key points:
  • TnI and TnT are normally absent from the circulation - any detectable level is significant
  • Troponin is the gold-standard marker - persists 7-10 days, allowing late diagnosis
  • With reperfusion: both troponin and CK-MB peak earlier due to rapid washout from necrotic tissue
  • CK-MB returns to normal days earlier than LDH, making LDH useful for confirming an older infarct

Other Diagnostic Tools

  • ECG: ST elevation (STEMI), ST depression/T-wave inversion (NSTEMI), new Q-waves (transmural necrosis), bundle branch block
  • Echocardiography: Regional wall motion abnormalities (hypokinesis, akinesis, dyskinesis)
  • Coronary angiography: Gold standard for identifying culprit artery; guides PCI
  • Radionuclide scanning: Technetium-99m sestamibi perfusion imaging
  • MRI: Most sensitive for detecting myocardial necrosis and viability

Complications of Myocardial Infarction

Nearly three-fourths of patients experience one or more complications. Three are potentially lethal:

Mechanical Complications (most dangerous)

ComplicationTimingDetails
Ventricular free wall rupture3-7 days (peak)Least common but most fatal; causes hemopericardium and cardiac tamponade
Ventricular septal rupture (VSD)3-7 daysMost common rupture; harsh new systolic murmur
Papillary muscle rupture3-7 daysCauses acute severe mitral regurgitation; flash pulmonary edema
Rupture timing: 3-7 days after MI when lysis of necrotic myocardium is maximal and the infarct has been converted to soft, friable granulation tissue (maximum vulnerability).

Functional Complications

  • Contractile dysfunction / Cardiogenic shock: Proportional to extent of LV damage; cardiogenic shock occurs in ~10% of transmural MIs, typically when >40% of LV is damaged
  • Papillary muscle dysfunction: Ischemia (without rupture) causes mitral regurgitation
  • Right ventricular infarction: Isolated in 1-3% of MIs; right-sided failure, systemic hypotension

Arrhythmias

  • Most common complication; major cause of early (pre-hospital) death
  • Ventricular fibrillation: leading cause of death within first hour of MI
  • Ventricular tachycardia, heart block, atrial fibrillation, sinus bradycardia (especially with inferior MIs via vagal stimulation)

Late / Chronic Complications

ComplicationMechanism
Pericarditis (Dressler syndrome)Autoimmune reaction 2-10 weeks post-MI; fibrinous epicardial inflammation
Mural thrombusWall motion abnormality over infarcted zone; risk of systemic embolism
Left ventricular aneurysmScar tissue bulges outward with each contraction; associated with persistent ST elevation
Progressive heart failureVentricular remodeling with myocyte hypertrophy and chamber dilation
Ventricular remodelingInfarct expansion + reactive hypertrophy of non-infarcted segments

Clinical Presentation (Brief)

  • Classic: crushing/squeezing chest pain >30 minutes, radiating to left arm/jaw, diaphoresis, nausea/vomiting, dyspnea
  • ~25% are entirely asymptomatic (especially diabetics with neuropathy) - discovered by ECG or biomarkers
  • Posterior-inferior MI: nausea/vomiting predominant (vagal stimulation)

Sources: Robbins & Kumar Basic Pathology, pp. 358-360; Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 511-516
This is a shared conversation. Sign in to Orris to start your own chat.